Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

2N Pharma ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   0.0% 0.0% 2.7% 1.8% 0.9% 2.0% 15.6% 15.4%   Credit score (0-100)   0 0 59 70 90 67 12 13   Credit rating   N/A N/A BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 5.1 943.7 1.4 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 336 1,538 2,222 543 0.0 0.0   EBITDA   0.0 0.0 -258 -1,423 148 -421 0.0 0.0   EBIT   0.0 0.0 -261 -1,440 130 -439 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 -248.5 -1,496.3 89.9 -491.8 0.0 0.0   Net earnings   0.0 0.0 -187.9 -318.5 270.1 -346.8 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 -249 -1,496 89.9 -492 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 52.0 102 84.9 67.0 0.0 0.0   Shareholders equity total   0.0 0.0 -148 8,863 11,048 10,701 -4,737 -4,737   Interest-bearing liabilities   0.0 0.0 9,952 5,750 6,029 6,505 4,737 4,737   Balance sheet total (assets)   0.0 0.0 10,834 16,778 19,663 21,813 0.0 0.0   Net Debt   0.0 0.0 3,758 4,977 4,632 4,950 4,737 4,737     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 336 1,538 2,222 543 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 357.9% 44.5% -75.6% -100.0% 0.0%   Employees   0 0 1 5 5 3 0 0   Employee growth %   0.0% 0.0% 0.0% 400.0% 0.0% -40.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 10,834 16,778 19,663 21,813 0 0   Balance sheet change%   0.0% 0.0% 0.0% 54.9% 17.2% 10.9% -100.0% 0.0%   Added value   0.0 0.0 -257.9 -1,423.3 146.3 -420.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 3,763 10,075 3,432 2,483 -19,809 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% -77.8% -93.6% 5.8% -80.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% -2.2% -10.2% 0.7% -2.1% 0.0% 0.0%   ROI %   0.0% 0.0% -2.3% -10.5% 0.7% -2.2% 0.0% 0.0%   ROE %   0.0% 0.0% -1.7% -3.2% 2.7% -3.2% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% -1.3% 52.8% 56.2% 49.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -1,457.2% -349.7% 3,132.6% -1,176.3% 0.0% 0.0%   Gearing %   0.0% 0.0% -6,727.5% 64.9% 54.6% 60.8% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.1% 1.1% 0.7% 0.9% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 26.3 5.4 5.1 0.9 0.0 0.0   Current Ratio   0.0 0.0 26.3 5.4 5.1 0.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 6,193.5 772.7 1,397.5 1,555.6 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 6,799.0 2,377.1 1,884.8 -337.8 -2,368.7 -2,368.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -258 -285 29 -140 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -258 -285 30 -140 0 0   EBIT / employee   0 0 -261 -288 26 -146 0 0   Net earnings / employee   0 0 -188 -64 54 -116 0 0